PRKN and Parkinson disease: Mitophagy‐associated proteins (MAPs), including PINK1, Parkin, PGAM5, BNIP3, and phosphorylated‐TBK1 (p‐TBK1), are, to our best knowledge, not well studied as a panel of biomarkers of neurodegeneration in PD.